(CHPY) Tidal Trust II - Ratings and Ratios
Semiconductor Stocks, Equity ETF, Covered Calls
Dividends
| Dividend Yield | 31.70% |
| Yield on Cost 5y | 52.23% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.4% |
| Value at Risk 5%th | 33.9% |
| Relative Tail Risk | -7.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.39 |
| Alpha | 62.26 |
| CAGR/Max DD | 10.85 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.447 |
| Beta | 1.509 |
| Beta Downside | 1.513 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.60% |
| Mean DD | 1.69% |
| Median DD | 0.56% |
Description: CHPY Tidal Trust II December 24, 2025
The Tidal Trust II Fund (US:CHPY) follows a two-pronged approach: it builds a concentrated equity portfolio of U.S.-listed semiconductor stocks (the “Equity Strategy”) and overlays an income-generating options program that trades options on those stocks and on semiconductor-focused ETFs (the “Options Strategies”). Because the fund is classified as non-diversified, its performance is highly sensitive to the fortunes of a limited set of semiconductor issuers.
Key industry metrics that shape the fund’s outlook include: (1) global semiconductor sales, which rose ~6 % YoY in Q3 2024, driven largely by AI-related demand; (2) U.S. fab capacity utilization, currently around 85 %, reflecting the impact of the CHIPS Act-funded capacity expansions; and (3) the average forward P/E of the top-10 U.S. semiconductor firms, hovering near 22×, indicating modest valuation pressure despite strong earnings growth. Macro-level drivers such as U.S. fiscal policy on chip subsidies and supply-chain resilience remain pivotal for the sector’s upside.
For a deeper quantitative assessment, you may want to explore the fund’s metrics on ValueRay to see how its risk-adjusted returns compare to peers.
What is the price of CHPY shares?
Over the past week, the price has changed by +2.46%, over one month by +13.54%, over three months by +15.09% and over the past year by +86.42%.
Is CHPY a buy, sell or hold?
What are the forecasts/targets for the CHPY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 93.1 | 51.4% |
CHPY Fundamental Data Overview January 24, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 234.2m USD (234.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 234.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 234.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 11.48% (E(234.2m)/V(234.2m) * Re(11.48%) + (debt-free company))
Discount Rate = 11.48% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)